Mounjaro 2.5 mg injection

Tirzepatide 2.5 mg injection is a once-weekly injectable medication used for the management of type 2 diabetes and, in certain indications, for chronic weight management. It works as a dual GIP and GLP-1 receptor agonist, helping to increase insulin secretion when blood glucose levels are elevated, reduce glucagon release, slow gastric emptying, and decrease appetite. The 2.5 mg dose is typically the starting dose used to help the body adjust to treatment before gradually increasing to higher maintenance doses. It supports improved blood sugar control and may contribute to weight reduction. Common side effects include nausea, vomiting, diarrhea, and decreased appetite, and it should be used under medical supervision.